First, we conducted a proliferation assay to compare the effects of the EZH2 inhibitor (iEZH2, Tazemetostat) and degrader (dEZH2, MS1943) on cell viability across various lymphoma cell lines. The gene discussed is EZH2; the disease is lymphoma.